L. Rydén

Endocrinology, Diabetes and Metabolism · 2000–2021

A researcher in the Science corpus: 11 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom L. Rydén trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. G. Moneta

Papers from L. Rydén's perspective

Ordered by how strongly the researchers L. Rydén trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. (Journal of the American Medical Association (JAMA))
  2. The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe. The Euro Heart Survey on diabetes and the heart. (European Heart Journal)
  3. Association of Diet, Exercise, and Smoking Modification With Risk of Early Cardiovascular Events After Acute Coronary Syndromes (Circulation)
  4. Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction. (Journal of the American Medical Association (JAMA))
  5. Medication nonadherence is associated with a broad range of adverse outcomes in patients with coronary artery disease. (American Heart Journal)
  6. Interventions to enhance medication adherence in chronic medical conditions: a systematic review. (Archives of Internal Medicine)
  7. Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64). (Kidney International)
  8. Fish intake, contaminants, and human health: evaluating the risks and the benefits. (Journal of the American Medical Association (JAMA))
  9. Trans fatty acids and cardiovascular disease. (New England Journal of Medicine)
  10. Intensive glucose control and macrovascular outcomes in type 2 diabetes (Diabetologia)

Their papers